Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 1,743 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Inpatients and Outpatients With Routine 12-lead ECG
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atrial Fibrillation, Vascular Risk
Interventions: clopidogrel (SR25990C); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 6,706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Coronary Artery Disease, Atherosclerosis, Heart Attack
Interventions: Statin, Aspirin tablet, Nexlizet, LEQVIO, Vascepa, Jardiance, Colchicine; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Health Behavior
Interventions: SomaSignal Test Results; Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 40 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obesity, Cardiovascular Disease, Type 2 Diabetes, Osteoporosis
Interventions: Observational Study; Other
Lead sponsor: Augusta University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Refractory Plasma Cell Myeloma
Interventions: Autologous Hematopoietic Stem Cell Transplantation, Bortezomib, Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis, Melphalan, Mycophenolate Mofetil, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation, Peripheral Blood Stem Cell Transplantation, Syngeneic Bone Marrow Transplantation, Total-Body Irradiation; Procedure · Drug · Other + 1 more
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Coronary Artery Disease
Interventions: Rosuvastatin; Drug
Lead sponsor: General University Hospital, Prague; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Maywood, Illinois • Iowa City, Iowa

Conditions: Compartment Syndromes, Compartment Syndrome of Lower Leg, Compartment Syndrome of Forearm
Interventions: Lower extremity and/or upper extremity surgery; Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Peripheral Artery Disease
Interventions: Fitbit Sub-Study; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 90 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Myeloma
Interventions: MEDI-551 Maintenance; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiovascular Diseases
Interventions: Medication Adherence System (MAS), Usual Care; Behavioral
Lead sponsor: PHCC LP; Industry
Eligibility: 19 Years to 80 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Pueblo, Colorado

Conditions: Cerebrovascular Accident
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 262 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 3
States / cities: Davis, California • Stanford, California • Grand Rapids, Michigan

Conditions: Cardiovascular Risk Factor, Blood Pressure, Exercise, Diet Modification, Health Promotion
Interventions: Circuit Training exercise & Modified Mediterranean diet; Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: San Marcos, California

Conditions: Stroke, Atherosclerosis
Interventions: High Risk - intensive coaching, High Risk - standard care, Low Risk - control; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Madison, Wisconsin • Oneida, Wisconsin

Conditions: Cardiovascular Diseases
Interventions: Eggs - 2 per day for breakfast, 1 packet of oatmeal per day; Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 30 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Multiple Myeloma
Interventions: Sirolimus, Tacrolimus, Lenalidomide; Drug
Lead sponsor: Sherif S. Farag; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Disease, Diabetes Mellitus, Hypertension, Congestive Heart Failure
Interventions: Social Risk Score and CDS Tool, Standard of Care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 5
States / cities: Baltimore, Maryland

Conditions: HIV/AIDS, Cardiovascular Risk Factors, Trauma, Psychological
Interventions: HHMB; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Los Angeles, California • Van Nuys, California

Conditions: Maternal Health, Infant Health, Hypertension, Behavioral Medicine, Mindfulness, Psychophysiology, Cardiovascular Diseases, Cardiovascular Diseases Risk
Interventions: Follow up to Mindfulness RCT using a Still Face Paradigm; Other
Lead sponsor: Lifespan; Other
Eligibility: 6 Months and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Plasma Cell Leukemia in Remission, Plasma Cell Myeloma
Interventions: Autologous Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Filgrastim, Laboratory Biomarker Analysis, Lenalidomide, pheresis, Melphalan, Palifermin, Total Marrow Irradiation; Procedure · Drug · Biological + 2 more
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Duarte, California

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: Blood Sample, HEART Score; Procedure · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years and older
Enrollment: 1,572 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 6
States / cities: Sacramento, California • Gainesville, Florida • Baltimore, Maryland + 3 more

Conditions: Cardiovascular Risk Factor
Interventions: Eggs, Choline Supplement; Other · Dietary Supplement
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 30 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: HIV, Inflammation
Interventions: Zinc gluconate; Dietary Supplement
Lead sponsor: Grace McComsey; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obstructive Sleep Apnea
Interventions: Forced Desynchrony; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study

Role of Cardiometabolic Risk Factors in Childhood Bone Development

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques

NIRST and ICG-based Perfusion Imaging in Acute Compartment Syndrome

PAD Registry and Fitbit Sub-Study Program

MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma

Evaluating the Effectiveness of a Computerized Medication Adherence System at Reducing Cardiovascular Disease Risk Factors

Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk

Exercise & Diet Effects on CV Risk in Firefighters

Stroke Prevention in the Wisconsin Native American Population

Eggs as Part of a Healthy Breakfast

Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

Social Risk Score, Clinical Decision Support Tool and Closed Loop Referral for Social Risk Screen and Referral

Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification

Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population

Zinc Supplementation and Cardiovascular Risk in HIV

Circadian Rhythms and Cardiovascular Risk